Mitosis Detection in the Wild: Multi-Tumor and Context-Aware Generalization in the MIDOG 2025 Challenge

• URL: http://arxiv.org/abs/2606.07368v1
• Date: Fri, 05 Jun 2026 15:11:08 GMT
• Title: Mitosis Detection in the Wild: Multi-Tumor and Context-Aware Generalization in the MIDOG 2025 Challenge
• Abstract summary: MItosis DOmain Generalization (MIDOG) 2025 was designed to evaluate algorithmic performance across unprecedented biological and contextual diversity.<n>We curated a test dataset of 365 cases, encompassing 12 distinct human, canine and feline tumor types.<n>In the AMF detection track, we had 21 submissions with balanced accuracy values up to 0.908.
• Score: 19.002373977515607
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Automated mitosis detection is a well-established task in computational pathology. While previous benchmarks focused on scanner-induced domain shift, clinical "real-world" application requires models to be robust across the vast variance to be expected in the histological landscape. The MItosis DOmain Generalization (MIDOG) 2025 challenge was designed to evaluate algorithmic performance across unprecedented biological and contextual diversity. We curated a test dataset of 365 cases, encompassing 12 distinct human, canine and feline tumor types, digitized across multiple scanning platforms. Moving beyond hand-selected hotspots, the challenge required detection also in random tissue areas (representative of the whole slide detection situation) and challenging areas (areas rich in hard negatives). In the second track, we introduced the classification of atypical mitotic figures (AMFs). There were 18 teams submitting to the detection track, with F1 scores ranging up to 0.740. In the AMF detection track, we had 21 submissions with balanced accuracy values up to 0.908. Our analysis reveals that while most models perform reliably in traditional hotspots, significant performance degradation occurs in challenging ROIs, where false positive rates tripled. Furthermore, performance varied significantly across the 12 tumor types, highlighting "blind spots" in current state-of-the-art architectures when encountering rare or highly pleomorphic malignancies. Moreover, we evaluated the effectiveness of ensembling and found a mean increases of 1.5 and 1.3 percentage points in F1 score and balanced accuracy, respectively. In contrast, TTA showed no relevant improvement. MIDOG 2025 demonstrates that "in the wild" mitosis detection remains a significant hurdle. The transition from hotspot-only evaluation to a multi-contextual framework provides a more realistic proxy for clinical reliability.

Related papers

• A Contrastive Variational AutoEncoder for NSCLC Survival Prediction with Missing Modalities [41.8469011437549]
  Predicting survival outcomes for non-small cell lung cancer (NSCLC) patients is challenging due to the different individual prognostic features.<n>State-of-the-art models rely on available data to create patient-level representations or use generative models to infer missing modalities.<n>We propose a Multimodal Contrastive Variational AutoEncoder (MCVAE) to address this issue.
  arXiv  Detail & Related papers  (2026-02-19T14:29:34Z)
• Deep Unsupervised Anomaly Detection in Brain Imaging: Large-Scale Benchmarking and Bias Analysis [42.60508892284938]
  We present a large-scale, multi-center benchmark of deep unsupervised anomaly detection for brain imaging.<n>We tested 2,221 T1w and 1,262 T2w scans spanning healthy datasets and diverse clinical cohorts.<n>Our benchmark establishes a transparent foundation for future research and highlights priorities for clinical translation.
  arXiv  Detail & Related papers  (2025-12-01T11:03:27Z)
• An Explainable Hybrid AI Framework for Enhanced Tuberculosis and Symptom Detection [55.35661671061754]
  Tuberculosis remains a critical global health issue, particularly in resource-limited and remote areas.<n>We propose a framework which enhances disease and symptom detection on chest X-rays by integrating two supervised heads and a self-supervised head.<n>Our model achieves an accuracy of 98.85% for distinguishing between COVID-19, tuberculosis, and normal cases, and a macro-F1 score of 90.09% for multilabel symptom detection.
  arXiv  Detail & Related papers  (2025-10-21T17:18:55Z)
• Challenges and Lessons from MIDOG 2025: A Two-Stage Approach to Domain-Robust Mitotic Figure Detection [9.314972045525133]
  This paper describes our participation in the MIDOG 2025 challenge, focusing on robust mitotic figure detection.<n>We developed a two-stage pipeline combining Faster R-CNN for candidate detection with an ensemble of three classifiers for false positive reduction.<n>Our best submission achieved F1-score 0.2237 (Recall: 0.9528, Precision: 0.1267) using a Faster R-CNN trained solely on MIDOG++ dataset.
  arXiv  Detail & Related papers  (2025-09-01T17:42:05Z)
• RF-DETR for Robust Mitotic Figure Detection: A MIDOG 2025 Track 1 Approach [0.0]
  This paper presents our approach for the MIDOG 2025 challenge Track 1, focusing on robust mitotic figure detection across diverse histological contexts.<n>We employed RF-DETR (Roboflow Detection Transformer) with hard negative mining, trained on MIDOG++ dataset.<n>On the preliminary test set, our method achieved an F1 score of 0.789 with a recall of 0.839 and precision of 0.746, demonstrating effective generalization across unseen domains.
  arXiv  Detail & Related papers  (2025-08-29T16:04:50Z)
• ConvNeXt with Histopathology-Specific Augmentations for Mitotic Figure Classification [1.398256265458105]
  We propose a solution based on the lightweight ConvNeXt architecture to maximize domain coverage.<n>On the preliminary leaderboard, our model achieved a balanced accuracy of 0.8961, ranking among the top entries.
  arXiv  Detail & Related papers  (2025-08-29T13:18:32Z)
• Robust Pan-Cancer Mitotic Figure Detection with YOLOv12 [1.2228119373158255]
  We present a mitotic figure detection approach based on the state-of-the-art YOLOv12 object detection architecture.<n>Our method achieved an F1-score of 0.801 on the preliminary test set (hotspots only) and ranked second on the final test leaderboard with an F1-score of 0.7216.
  arXiv  Detail & Related papers  (2025-08-29T08:37:46Z)
• A bag of tricks for real-time Mitotic Figure detection [0.0]
  We build on the efficient RTMDet single stage object detector to achieve high inference speed suitable for clinical deployment.<n>We employ targeted, hard negative mining on necrotic and debris tissue to reduce false positives.<n>On the preliminary test set of the MItosis DOmain Generalization (MIDOG) 2025 challenge, our single-stage RTMDet-S based approach reaches an F1 of 0.81.
  arXiv  Detail & Related papers  (2025-08-27T11:45:44Z)
• PathBench: A comprehensive comparison benchmark for pathology foundation models towards precision oncology [33.51485504161335]
  We present PathBench, the first comprehensive benchmark for pathology foundation models (PFMs)<n>Our framework incorporates large-scale data, enabling objective comparison of PFMs.<n>We have collected 15,888 WSIs from 8,549 patients across 10 hospitals, encompassing over 64 diagnosis and prognosis tasks.
  arXiv  Detail & Related papers  (2025-05-26T16:42:22Z)
• Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge [44.76736949127792]
  We describe the design and results from the BraTS 2023 Intracranial Meningioma Challenge.<n>The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas.<n>The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor.
  arXiv  Detail & Related papers  (2024-05-16T03:23:57Z)
• Adapting Visual-Language Models for Generalizable Anomaly Detection in Medical Images [68.42215385041114]
  This paper introduces a novel lightweight multi-level adaptation and comparison framework to repurpose the CLIP model for medical anomaly detection. Our approach integrates multiple residual adapters into the pre-trained visual encoder, enabling a stepwise enhancement of visual features across different levels. Our experiments on medical anomaly detection benchmarks demonstrate that our method significantly surpasses current state-of-the-art models.
  arXiv  Detail & Related papers  (2024-03-19T09:28:19Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.